OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Endocrinology is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Exposing skin to ultraviolet irradiation increases food intake in male individuals	834
Author Correction: Adrenocortical stem cells in health and disease	716
Immune cell population prevents weight regain	666
Dexamethasone in patients with diabetes mellitus	641
CNOT6L regulates hepatokine expression	488
Memory of obesity stored in adipocytes	453
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	437
Non-nutritive sweeteners — too sweet to be wholesome?	278
Timed high-fat diet feeding restores small bowel circadian rhythms	248
The role of DNA damage in diabetic complications	219
Effects of diet on atherosclerotic plaque development	199
The challenges of assessing adiposity in a clinical setting	198
Thyroid function and iodine intake: global recommendations and relevant dietary trends	193
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	184
Limiting the use and misuse of liothyronine in hypothyroidism	179
The gut microbiota in obesity and weight management: microbes as friends or foe?	176
Ketosis improves muscle stem cell resilience	165
Metabolite levels during the menstrual cycle	162
Patients’ insights into diabetes insipidus	160
mTORC1 is the central regulator in pancreatic β-cells	159
Neurons in the diagonal band of Broca moderate food intake	156
Reply to ‘Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines’	140
Ensuring diverse representation and minimizing conflicts of interest in clinical practice guidelines	128
The interactions between energy homeostasis and neurovascular plasticity	124
Midlife and the menopause transition in type 2 diabetes mellitus prevention	123

Steroid hormones as modulators of anti-tumoural immunity	121
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus	120
Obesity phenotypes: explaining the unexplained	117
Reply to ‘Why the science on T3 and genomics is not settled’	116
Negative regulator of GDF15 signalling identified	116
Fusion with blood vessel organoids supports pancreatic islet function	111
A pivotal year for NAFLD and NASH therapeutics	106
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity	103
Primary aldosteronism — a multidimensional syndrome	103
New role for bone marrow adipocytes in obesity	97
A role for phosphocreatine in adipose inflammation	92
Genetic risk scores improve prediction of obesity in survivors of childhood cancer	89
Language evolves — so can you	88
Urocortin 3 function in glucose metabolism	85
RalA links obesity and mitochondrial dysfunction	82
New maps and new challenges in the post-genomic era	81
A role for the kidney in metformin action	81
Progress in islet transplantation is more important than ever	80
The metabolic mythos of ketones	79
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus	79
Inflammation-induced adrenal dysfunction	76
Signals from the dorsal motor nucleus of the vagus promote jejunal fat absorption	75
Advances in incretin-based therapeutics for obesity	72
Advances in basic biology and translation in islet research	71
Epigenetic effects of maternal type 1 diabetes mellitus	69
Luteal phase support in assisted reproductive technology	66
Bone and muscle crosstalk in ageing and disease	65
Endosomal trafficking in metabolic homeostasis and diseases	64
Targeting the incretin system in obesity and type 2 diabetes mellitus	64
Untangling the pathways of SDHx loss of function	63
Triggering puberty in primates: is it NPY?	61
Potential downsides of calorie restriction	60
Leptin–thyroid hormone axis affects energy use in muscle	60
The metabolic benefits of exercise-induced hepatic autophagy	60
Author Correction: Drug Insight: selective agonists and antagonists of the glucocorticoid receptor	60